SB 1169 Pennsylvania Senate · 2023-2024 Regular Session

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for definitions and for drug overdose medication.

SB 1169 amends Pennsylvania's Controlled Substance Act to formally define key terms like "opioid" and "emergency opioid antagonist," which includes drugs such as naloxone used to reverse overdoses. The bill requires the Department of Health to update training and protocols for emergency medical services providers, law enforcement, firefighters, and other groups to recognize overdoses and administer reversal medication safely. It also mandates the creation of free, age-appropriate educational materials for schools, correctional facilities, and the general public to reduce stigma and promote safe use of these life-saving drugs. Additionally, the legislation allows law enforcement agencies and fire departments to enter agreements to obtain supplies of emergency opioid antagonists after their personnel complete the required training.
Bill status in committee 1 of 4 stages cleared
Introduction
May 2024
Committee Review
Floor Vote
Governor
Introduced May 16, 2024 Last action May 16, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
1
May 16, 2024
Committee
Referred to Health & Human Services
upper
1 primary · 8 co-sponsors

Sponsors